this findings propose that hepcidin may influence the regulation of tumor growth and metastasis, thereby advocating its potential utility as a biomarker to enhance prognostic assessment and inform therapeutic strategies in breast cancer patients. This evidence concerns the gene HAMP and breast cancer.